ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS
摘要
The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN18.2.
申请公布号
SG11201406472W(A)
申请公布日期
2014.11.27
申请号
SG11201406472W
申请日期
2013.05.06
申请人
GANYMED PHARMACEUTICALS AG;TRON- TRANSLATIONALE ONKOLOGIE AN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBH
发明人
SAHIN, UGUR;TÜRECI, ÖZLEM;MITNACHT-KRAUS, RITA;WÖLL, STEFAN
